FTC may need to update studies on competitive effects of generic pharma mergers, Wright says
The US Federal Trade Commission may need to update its economic studies on the impact of consolidation in the generic pharmaceutical market if the agency wants to continue to rely on...To view the full article, register now.
Already a subscriber? Click here to view full article